Age 18 years or older
Symptomatic or asymptomatic coronary artery disease patients
MLA(minimal luminal area)<4mm2
plaque burden>70%
Lipid-rich plaque on NIRS(Intracoronary Near-Infrared Spectroscopy) (defined as maxLCBI4mm>315)
2 target vulnerable lesions
Eligible for percutaneous coronary intervention with Absorb Bioresorbable Vascular Scaffold or Everolimus Eluting Stent
Willing and able to provide informed written consent
Reference vessel diameter 2.75-4.0
Lesion length = 40

NCT02316886_inc_T1
Person
Age
NCT02316886_inc_T2
Value
18 years or older
NCT02316886_inc_T3
Qualifier
asymptomatic
NCT02316886_inc_T4
Condition
coronary artery disease
NCT02316886_inc_T5
Qualifier
Symptomatic
NCT02316886_inc_T6
Scope
Symptomatic or asymptomatic
NCT02316886_inc_T7
Measurement
MLA
NCT02316886_inc_T8
Measurement
minimal luminal area
NCT02316886_inc_T9
Value
<4mm2
NCT02316886_inc_T10
Measurement
plaque burden
NCT02316886_inc_T11
Value
>70%
NCT02316886_inc_T12
Condition
Lipid-rich plaque
NCT02316886_inc_T13
Procedure
NIRS
NCT02316886_inc_T14
Procedure
Intracoronary Near-Infrared Spectroscopy
NCT02316886_inc_T15
Measurement
maxLCBI4mm
NCT02316886_inc_T16
Value
>315
NCT02316886_inc_T17
Multiplier
2
NCT02316886_inc_T18
Condition
target vulnerable lesions
NCT02316886_inc_T19
Mood
Eligible for
NCT02316886_inc_T20
Procedure
percutaneous coronary intervention
NCT02316886_inc_T21
Device
Absorb Bioresorbable Vascular Scaffold
NCT02316886_inc_T22
Device
Everolimus Eluting Stent
NCT02316886_inc_T23
Scope
Absorb Bioresorbable Vascular Scaffold or Everolimus Eluting Stent
NCT02316886_inc_T25
Measurement
Reference vessel diameter
NCT02316886_inc_T26
Value
2.75-4.0
NCT02316886_inc_T27
Measurement
Lesion length
NCT02316886_inc_T28
Value
= 40